Common Contracts
2 similar Investor Rights Agreement contracts by Agios Pharmaceuticals Inc
EX-4.2 4 d538215dex42.htm EX-4.2 Execution Copy AGIOS PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT November 16, 2011 Page Recitals 1 - i - Exhibit A – List of Purchasers - ii - AGIOS PHARMACEUTICALS, INC. SECOND AMENDED...Investor Rights Agreement • May 5th, 2020 • Delaware
This Agreement dated as of November 16, 2011 is entered into by and among Agios Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Lewis Cantley, Tak Mak, Craig Thompson and Michael Su (individually, a “Founder” and collectively, the “Founders”), and the individuals and entities listed on Exhibit A attached hereto (the “Purchasers”).
AGIOS PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT November 16, 2011Investor Rights Agreement • May 23rd, 2013 • Agios Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Agreement dated as of November 16, 2011 is entered into by and among Agios Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Lewis Cantley, Tak Mak, Craig Thompson and Michael Su (individually, a “Founder” and collectively, the “Founders”), and the individuals and entities listed on Exhibit A attached hereto (the “Purchasers”).
